Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gabriel Steg

Showing results (621-630 of 962) with videos related to

Pageof 97
Sort By:
American Heart Journal Plus : Cardiology Research and Practice|March 29, 2024
Efficacy and safety of cangrelor in patients with peripheral artery disease undergoing percutaneous coronary intervention - Insights from the CHAMPION programJ Antonio Gutierrez, Robert A Harrington, Gregg W Stone, et al.
Open Heart|December 12, 2017
Early clinical outcomes as a function of use of newer oral P2Y<sub>12</sub> inhibitors versus clopidogrel in the EUROMAX trialKurt Huber, Gregory Ducrocq, Christian W Hamm, et al.
Circulation|March 20, 2016
Diabetes Mellitus and Prevention of Late Myocardial Infarction After Coronary Stenting in the Randomized Dual Antiplatelet Therapy StudyIan T Meredith, Jean-François Tanguay, Dean J Kereiakes, et al.
The American Journal of Medicine|January 25, 2006
Impact of the history of congestive heart failure on the utility of B-type natriuretic peptide in the emergency diagnosis of heart failure: results from the Breathing Not Properly Multinational StudyAdam Strunk, Vikas Bhalla, Paul Clopton, et al.
Circulation|September 14, 2013
Stroke and outcomes in patients with acute type A aortic dissectionEduardo Bossone, David C Corteville, Kevin M Harris, et al.
American Heart Journal|March 30, 2013
Radial versus femoral access, bleeding and ischemic events in patients with non-ST-segment elevation acute coronary syndrome managed with an invasive strategyMarc W Klutstein, Cynthia M Westerhout, Paul W Armstrong, et al.
Circulation|October 31, 2013
Biomarkers in relation to the effects of ticagrelor in comparison with clopidogrel in non-ST-elevation acute coronary syndrome patients managed with or without in-hospital revascularization: a substudy from the Prospective Randomized Platelet Inhibition and Patient Outcomes (PLATO) trialLars Wallentin, Daniel Lindholm, Agneta Siegbahn, et al.
Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|November 9, 2020
Dual antithrombotic therapy with dabigatran in patients with atrial fibrillation after percutaneous coronary intervention for ST-segment elevation myocardial infarction: a post hoc analysis of the randomised RE-DUAL PCI trialUwe Zeymer, Orly Leiva, Stefan H Hohnloser, et al.
Cerebrovascular Diseases (Basel, Switzerland)|January 16, 2017
The Intracranial-B2LEED3S Score and the Risk of Intracranial Hemorrhage in Ischemic Stroke Patients Under Antiplatelet TreatmentPierre Amarenco, Leila Sissani, Julien Labreuche, et al.
The American Journal of Medicine|June 26, 2012
An international model to predict recurrent cardiovascular diseasePeter W F Wilson, Ralph D'Agostino, Deepak L Bhatt, et al.
Pageof 97

Showing results (621-630 of 962) with videos related to

Sort By:
Pageof 97
American Heart Journal Plus : Cardiology Research and Practice|March 29, 2024
Efficacy and safety of cangrelor in patients with peripheral artery disease undergoing percutaneous coronary intervention - Insights from the CHAMPION programJ Antonio Gutierrez, Robert A Harrington, Gregg W Stone, et al.
Open Heart|December 12, 2017
Early clinical outcomes as a function of use of newer oral P2Y<sub>12</sub> inhibitors versus clopidogrel in the EUROMAX trialKurt Huber, Gregory Ducrocq, Christian W Hamm, et al.
Circulation|March 20, 2016
Diabetes Mellitus and Prevention of Late Myocardial Infarction After Coronary Stenting in the Randomized Dual Antiplatelet Therapy StudyIan T Meredith, Jean-François Tanguay, Dean J Kereiakes, et al.
The American Journal of Medicine|January 25, 2006
Impact of the history of congestive heart failure on the utility of B-type natriuretic peptide in the emergency diagnosis of heart failure: results from the Breathing Not Properly Multinational StudyAdam Strunk, Vikas Bhalla, Paul Clopton, et al.
Circulation|September 14, 2013
Stroke and outcomes in patients with acute type A aortic dissectionEduardo Bossone, David C Corteville, Kevin M Harris, et al.
American Heart Journal|March 30, 2013
Radial versus femoral access, bleeding and ischemic events in patients with non-ST-segment elevation acute coronary syndrome managed with an invasive strategyMarc W Klutstein, Cynthia M Westerhout, Paul W Armstrong, et al.
Circulation|October 31, 2013
Biomarkers in relation to the effects of ticagrelor in comparison with clopidogrel in non-ST-elevation acute coronary syndrome patients managed with or without in-hospital revascularization: a substudy from the Prospective Randomized Platelet Inhibition and Patient Outcomes (PLATO) trialLars Wallentin, Daniel Lindholm, Agneta Siegbahn, et al.
Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|November 9, 2020
Dual antithrombotic therapy with dabigatran in patients with atrial fibrillation after percutaneous coronary intervention for ST-segment elevation myocardial infarction: a post hoc analysis of the randomised RE-DUAL PCI trialUwe Zeymer, Orly Leiva, Stefan H Hohnloser, et al.
Cerebrovascular Diseases (Basel, Switzerland)|January 16, 2017
The Intracranial-B2LEED3S Score and the Risk of Intracranial Hemorrhage in Ischemic Stroke Patients Under Antiplatelet TreatmentPierre Amarenco, Leila Sissani, Julien Labreuche, et al.
The American Journal of Medicine|June 26, 2012
An international model to predict recurrent cardiovascular diseasePeter W F Wilson, Ralph D'Agostino, Deepak L Bhatt, et al.
Pageof 97